VBLOC® – Vagal Blocking Therapy for Weight Reduction  VBLOC® is a first-in-class weight loss treatment designed to treat a range of gastrointestinal and metabolic diseases. Delivered by a pacemaker-like device called the Maestro® Rechargeable System,VBLOC Therapy is designed to block vagal nerve signaling between the brain and stomach believed to …

A study of 509 type 2 diabetes patients found that lorcaserin was more effective than diet and exercise alone in reducing A1C levels regardless of whether the patients lost weight. The patients, randomly assigned to either lorcaserin or placebo along with diet and exercise, had A1c levels between 7% and …

Most adults exercising on a treadmill correctly identified light effort but underestimated how much added intensity would be needed to push their workout to a moderate or intense level. Also, only 24% of study participants correctly gauged how much to increase their pace to what would be considered a brisk …

Patients with heart disease or diabetes were more likely than those without the conditions to remain on statin therapy, according to a study. Among patients without heart disease or diabetes, those who were most likely to continue taking statins were overweight/obese or former smokers. The researchers also found that heavy …

According to multiple presentations, IDegLira, the fixed combination of insulin degludec and liraglutide, showed long-term efficacy across a range of body mass indices and parameters for type 2 diabetes patients…. 

Consuming healthier foods improves risk independently of other lifestyle changes such as weight loss or physical activity…. 

Results from dulaglutide’s sixth AWARD trial showed once-weekly dulaglutide 1.5mg was non-inferior to once-daily liraglutide 1.8mg when compared to metformin…. 

A large database analysis has found that two oral diabetes drug classes, thiazolidinediones (TZDs) and sulfonylureas, both increase the risk for fractures when compared with metformin…. 

Diabetic patients who received bariatric surgery saw greater weight loss and fewer macrovascular and microvascular complications than those treated with usual care…. 

The United States has 3 million more diabetic patients today than in 2010….